Pulmonx Corporation provided earnings guidance for the full year 2023. The company continues to expect revenue for the full year 2023 to be in the range of $63 million to $65 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.77 USD | -7.75% |
|
-16.86% | -54.75% |
Jun. 04 | Lake Street Initiates Pulmonx With Buy Rating, $12 Price Target | MT |
May. 01 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.75% | 224M | |
+75.67% | 12.57B | |
-25.35% | 7.28B | |
+14.52% | 5.47B | |
-20.06% | 4.73B | |
+14.91% | 4.09B | |
-23.83% | 3.78B | |
-30.22% | 2.63B | |
+42.93% | 2.3B | |
-1.98% | 2.03B |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Pulmonx Corporation Provides Earnings Guidance for the Full Year 2023